A modification of "reverse chromosome painting" was carried out using genomic DNA from tumor cells as a complex probe for chromosomal in situ suppression hybridization to normal metaphase chromsome spreads. Amplified DNA sequences contained in such probes showed specific signals, revealing the normal chromosome positions from which these sequences were derived, As a model system, genomic DNAs were analyzed from three tumor cell lines with amplification units including the proto
Introduction
Following the discovery of amplified genes in cultured cells selected for drug resistance or responding to environmental stress, specific amplification of genomic sequences has also been discovered in numerous tumors. Amplified sequences in tumor genomes frequently contain specific proto-oncogenes (Atitalo and Schwab 1986) . Cytogenetic analysis of tumor cell cultures has revealed that amplified DNA can be present either in double minute chromosomes (DMINs), small acentric chromosome-like structures that are frequently paired, or in homogeneously staining chromosomal regions (HSRs), visible with intermediate intensity using conventional banding techniques. However, our knowledge of the complexities of amplified sequences in primary tumors is still very limited.
Since the chromosomal origin of sequences in DMINs and HSRs cannot be determined by the analysis of banded chromosomes, assessment of the amplified genes is usually carried out by in situ and Southern blot hybridization of large numbers of proto-oncogene probes. However, these analyses rely entirely on the availability of suitable probe panels. In addition, co-amplified regions might often not be identified.
In the case of in situ hybridization, high quality metaphase spreads are required from the cells to be analyzed. However, in many cases (as in certain hematological and many solid tumors) such metaphases cannot be obtained. The possibilities of carrying out such an analysis on interphase nuclei (BarAm et al. 1992 ) remain restricted.
In the present study, an alternative approach is applied to analyze unknown amplified regions of a genome (Kallioniemi et al. 1992) . This approach provides a new example of a strategy termed "reverse chromosome painting" (Carter et al. 1992) . The principles of this procedure are outlined schematically in Fig. 1 . The first applications of this approach were presented in studies investigating the chromosomal content of interspecies hybrid cells (Boyle et al. 1990 ; Kievits et al. 1990 ). The whole genomic DNA of a hybrid cell line was used as a probe for chromosomal in situ suppression (CISS) hybridization on metaphase spreads from normal cells of a species of interest. By this approach, all chromosomes and chromosomal segments of this species present in the hybrid cell were easily identified. Further improvements of this approach were achieved by species-specific polymerase chain reaction (PCR) amplification products from such hybrid lines (Lengauer et al. 1990; Lichter et al. 1990 ). Reverse chromosome painting has also been successfully used to identify marker chromosomes in disease cases. After flow sorting of a marker chromosome, its DNA was amplified and used as a probe for CISS hybridization to normal human chromosomes (Telenius et al. 1992 ). This allows the rapid identification of the origin(s) of the marker chromosome. Reverse chromosome painting also allows a comprehensive analysis for identifying imbalanced chromosomal material of entire genomes when using the whole genomic DNA as a probe (see also Kallioniemi et al. 1992 and the accompanying paper by du Manoir et al. 1993 ).
In the present study, we demonstrate the application of reverse chromosome painting to identify the chromosomal origin of amplified regions using genomic tumor cell DNA as a probe. First, three cell lines were analyzed with amplification units containing the proto-oncogene c-myc. Secondly, a primary glioblastoma multiforme (GBM) tumor was investigated, in which Southern blot analysis suggested multiple copies of the epidermal growth factor receptor (EGFR) gene.
Materials and methods

Tumor material
The cell lines Colo320-HSR and HL-60 were both obtained from the American Type Culture Collection. Colo320-HSR was derived from a colon tumor (Alitalo et aL 1983) and HL-60 from a promyelocytic leukemia (Collins and Groudine 1982; Dalla Favera et al. 1982) . The cell line NCI-H60 was established from a small cell lung cancer (Little et al. 1983) . Tumor 978/90 was derived from a male patient with GBM according to the World Health Organization (WHO) classification (Zfilch 1979) . Diagnosis was based on histological examination of paraffin-embedded tissue sections and confirmed on tissue that was frozen, and finally stained with hematoxylin-eosin.
Preparation of tumor DNA
Cell lines Colo320-HSR and HL60 were propagated in RPMI1640 supplemented with 10% fetal calf serum. Tissue samples of the glioblastoma tumor 978/90 were frozen in liquid nitrogen immediately after surgery and then stored at -80~ Genomic DNA was prepared by standard methods (Maniatis et al. 1982 ) applying proteinase K digestion, phenol and chloroforrn/isoamylalcohol (24:1) extraction, and was finally precipitated with ethanol. DNA from cell line NCI-H60 was kindly provided by J. D. Minna, NIH, Bethesda, Md.
Cloned probes
Cosmid cos-myc72 containing an insert of about 30 kb from the c-myc gene (MYC) was originally isolated from a cosmid library of the Burkitt's lymphoma cell line IARC/BL72 (Joos et al. 1992) . For detection of the EGFR gene (c-erb-1), a c-DNA clone termed pECE-EGFR (3.8-kb Sall-Xhol fragment, Haley et al. 1987) was available. This clone spans almost the whole transcription unit, except for the last exon.
In situ hybridization
Metaphase chromosomes of normal blood lymphocytes (46,XY) were prepared according to standard protocols of colcemid arrest, hypotonic treatment and methanol/acetic acid (3:1) fixation. The protocol used for in situ hybridization is described in detail in Lichter and Cremcr (1992) . DNA was labeled by nick nanslation in the presence of either diguxigenin-I 1-dUTP or biotin-I 1-dUTP. For a 12-btl hybridization volume, 0.3-1 [,tg biotinqabeled or digoxigenin-labeled tumor DNA was corn bined with 50 gg Cotl fraction of human DNA. When tumor DNA was co-hybridized with individual cloned probes, 60 ng digoxigenin-labeled cos-myc72 or 200 ng biotin-labeled pECE-EGFR was added to the labeled tumor DNA. Denatured probe was pre-annealed for 15 min at 37~ and hybridized to denatured chromosomes for 24 h. Following post hybridization washes to a final stringency of 0.1 x SSC at 60~ hybridized DNA was detected via fluorescein isothiocyanate (FITC)-conjugated avidin and anti-digoxigenin rhodamine. Hybridization signals of pECE-EGFR were amplified according to Pinkel et al. (1986) . Chromosomes were counterstained with 4,6-diamino-2-phenyl-indole (DAPI). Slides were inspected directly using a conventional epifluorescence microscope and signals were counted to define hybridization efficiency. An additional analysis was performed using digitized images of F1TC, rhodamine or DAP1 fluroescence acquired with a cooled chargedcouple device (CCD) camera (Photometrics, Tuscon, Ariz.). For documentation, images of different fluorochrumes from the same object were overlaid electronically following careful realignment using the software package Gene Join (Yale University) as described (Ried et al. 1992 ). Prior to overlaying, thresholding was applied to images obtained from the genomic DNA hybridization in order to show only the peak fluorescence. Photographs of digitized images were taken directly from the monitor.
Results
Detection of amplified 8q24 sequences containing c-myc
The reverse chromosome painting technique was first applied for the detection of amplified sequences by using DNA from three tumor cell lines with a known amplification of the proto-oncogene c-myc. As listed in Table 1 , the c-myc amplification unit in Colo320-HSR, HL60 and NCI-H60 differes with respect to length and copy number. All tumor DNAs labeled the whole set of normal chromosomes. Above this general staining, highly specific fluorescence signals on 8q24 were obtained with each of the three tumor DNAs (see Table  1 ). One example is presented in Fig. 2A , B. The signal specificity was independent of the fluorochrome used for detection. Of the evaluated metaphases, 80%-95% showed intense fluorescence signals on 8q24 (59%-84% on both homologs). In CCD images, a threshold analysis confirmed that the peak fluorescence intensities were always observed over band 8q24. Other signals of corresponding intensity were rarely observed and were considered to be background, since they did not appear consistently on the same chromosome region. Two signals could be seen in most interphase nuclei. Co-hybridization experiments were carried out with cosmyc72 as a probe to test further whether the signals observed after reverse chromosome painting of genomic DNA from the three cell lines were generated by amplified sequences containing c-myc. These experiments demonstrated that the signals from tumor and cosmid DNA were co-localized in all metaphase spreads analyzed from the three tumor cell lines. One example is shown in Fig. 2B .
Amp/ification of two genomic regions containing proto-onco~enes in a glioblastoma tumor
To test the potential of reverse chromosome painting for the detection of amplified DNA sequences in primary tumor material, we performed an analysis with DNA from a case of GBM. Southern blot analysis of this case indicated an amplification of the EGFR gene (previous symbol: ERBB; formerly avian erythroblastic leukemia viral (v-erb-b) oncogene homolog) located on chromosome 7p13. Reverse chromosome painting using the tumor DNA as probe revealed highly intense hybridization signals on 12q 13-q 15 (see Fig. 2C-E) . In addition, a weaker signal was seen on 7p12-p13, consistently above the general chromosome staining. Both signals could be easily identified by conventional microscopy. Their specificity was also confirmed by a threshold analysis of CCD images as described above. A total of 32 digitized images was analyzed: the chromosome 12 signal was found on both homologs in 100% of the metaphase spreads, whereas 12.5% exhibited the signal on one and 87.5% on both chromosome 7 homologs. Unexpectedly, the signal on 12q was much stronger compared with that on 7p (see Fig. 2C ). Analysis of elongated chromosomes revealed that it is con> posed of two spatially separated signals, a highly intense signal on 12q 14-15, and a proximal weaker signal, located most probably on 12q13 (see Fig. 2E ). Interestingly the two labeled regions 7p13 and 12q13 carry homologous sequences (see Discussion).
Using an EGFR c-DNA as a co-hybridization probe, the corresponding signal was found to co-localize with the tumor DNA signal on 7p (Fig. 2D ) in all metaphase spreads analyzed (n = 32). In addition, a second, much weaker signal was found to co-localize with the major tumor DNA signal on band 12q13-q15. This minor signal was seen in 15% of the metaphase spreads on both chromosomes 12, and in 37cA on one chromosome 12 homolog. Thus, both the tumor DNA and the EGFR c-DNA probe generated two signals at the same chromosomal sites. However, the major signal obtained with the tumor DNA was on 12% whereas the major signal obtained with the c-DNA was on 7p.
Visual inspection of CCD images by several independent observers of normal metaphase spreads painted with the glioblastoma tumor DNA consistently revealed a weaker staining of both chromosomes 10 and the X chromosome ( Fig. 2C; for details of the evaluation procedure, see du Manoir et al. 1993 ). This observation can be attributed to a Fig. 2A-E . Reverse chromosome painting of normal chromosomes with a genomic tumor DNA. A-CCD image of a normal human metaphase spread, 46(XY), after CISS hybridization with biotin-labeled genomic DNA of the tumor cell line HL60. The hybridized probe was detected via FITC. Above the general level of chromosome painting, two highly intense signals are visible on chromosome 8q24 (arrows). B The same metaphase spread after overlaying of three digitized images each obtained from a different fluorochrome: (1) DAPI-stained chromosomes shown in blue; (2) the FITC image presented in A after a thresholding procedure to delineate only the peak fluorescence intensities, and showing green spots demonstrating the location of the most intense signals on 8q24; (3) digoxigenin-labeled probe for c-myc detected via rhodamine (rod spots). For illustration purposes, the image of the c-myc probe was shifted by two pixels to resolve the green and red signals. C Gray level CCD image of a normal metaphase chromosome spread hybridized with genomic DNA from a glioblastoma (GBM) carrying an amplification of the EGFR gene on chromosome 7p13. Digoxigenin-labeled tumor DNA was detected via rhodamine. Specific signals with high fluorescent intensity appear on the short arm of chromosome 7 (7p13) and, even stronger, on the long arm of chromosome 12 (12q13~115). Note the weak labeling of the X chromosome and both chromosome 10 homologs suggesting an under-representation of these chromosomes in the tumor. D The same metaphase as in C presented after overlaying of three pseudocolored digitized images as described in B~ DAPI-banded chromosomes are shown in blue, the rhodamine image of C (optimized to show the peak fluorescence) is seen in red. A co-hybridized EGFR probe, biotin-labeled and detected via FITC, is shown in green (arrows). Note the co-localization of the EGFR signal and the tumor DNA signal on 7pl 3. E Partial prometaphase chromosome spread showing the hybridization signals on chromosome 12 obtained with biotinylated GBM DNA. Note that two signals (arrows) can be detected, a proximal weaker signal (most probably on 12q13) and a distal, much stronger signal (12q14-q15) loss of chromosome 10 and the hemizygosity of the X chromosome in the tumor genome derived from a male patient (see Discussion).
Discussion
In this study, we have demonstrated that amplified sequences can be readily detected by in situ hybridization of total genomic DNA to normal human chromosomes. The corresponding signals are immediately visible in the microscope. Reverse chromosome painting was carried out using the DNA of three tumor cell lines in which the proto-oncogene MYC is known to be amplified. The efficiency in visualizing chromosomal band 8q24 harboring MYC roughly correlated to the amount of sequences over-represented in the probe DNA. The cell line Colo-320 containing most of the additional sequences (16-32 copies of an amplification unit of more than 600 kb) showed the highest efficiency (95%) in delineating the corresponding region on one or both homologs (see Table 1 ). The lowest efficiency (80%) was seen with cell line HL-60, which contains the smallest amount of multiplied DNA (approximately 20 copies of about 90 kb). Thus, the sensitivity of the approach is at least in the range of detecting a 20-fold multiplication of a fragment approximately 100 kb in length. By analogy to gene mapping experiments, it is expected that signals on 30%40% of the metaphases are sufficient to define a specifically labeled region. Therefore, the sensitivity defined by HL-60 in this report is probably an under-estimation of the general sensitivity of the approach. It should be noted that the typical length of amplification units described so far is between 200 and 2000 kb (Ruppert et al. 1991) . This range includes the c-myccontaining units of the cell lines Colo320-HSR and NCI-H60 investigated in this study.
In addition to the highly intense signals on 8q24, the fluorescence along all chromosomes appeared not to be evenly distributed. The impact of such a distribution on the diagnosis of gains and losses of chromosomal regions is discussed below and analyzed in detail in du Manoir et al. (1992) .
The reverse chromosome painting approach was also used to analyze a case of GBM. In this tumor, the recurrent chromosome aberrations found by karyotype analysis are gains of chromosome 7, losses of chromosomes 10 and 22, and gonosomes. DMINs are found in 30%-50% of the cases (Sandberg 1990) . Amplification of EGFR has been found in 29%-50% of GBM cases (Fuller and Bigner 1992) and has also been detected by Southern blot analysis in the case analyzed in this study. This finding could be confirmed by reverse chromosome painting using the tumor DNA; a specific signal on band 7p13 co-localized with an EGFR hybridization signal. The additional split signal on the long arm of chromosome 12 was unexpected. The weaker signal on 12q13 could be explained by cross-hybridization of the EGFR sequences contained in the tumor DNA to ERBB3, a homolog of the EGFR gene family mapping to 12q13. Coamplification of the ERB3 region can be considered as an alternative explanation.
The major signal on chromosome 12q14-q15 obtained with the GBM tumor DNA was much stronger than the signal on 7p13. Since the Southern blot data independently revealed an amplification of EGFR, the signal on 7pl 3 cannot be completely explained by a cross-hybridization of amplified 12q sequences. Thus, co-amplification of sequences in both chromosomal regions is the most probable explanation for our findings. Notably, numerous genes that are located within 12q13-q15 have been found to be involved in tumorigenesis (Craig and McBride 1991) , including the glioma-associated oncogene homolog (GLI), a member of the Krtippel family of zinc finger protein genes. This gene maps to 12q 13-q14 and has been found to be amplified in about 2%-4% of glioblastomas (Fuller and Bigner 1992) . Further proto-oncogenes that might be contained in the amplified or co-amplified regions are the ras homolog RAP1B (12q14), the melanomaassociated antigen CD63 gene (12q 12-q 13), the retinoic acid receptor gene RAR-gamma (RARG on 12q13), and the int-1 proto-oncogene (WNT1, former INT1, on 12q13) . Thus, the results obtained by reverse chromosome painting have rapidly provided a series of candidate genes that might be amplified and that may possibly play a pathogenetic role in this tumor.
Until now, analysis of the material constituting DMINs relied on hybridization experiments of candidate sequences. As a rule, large batteries of proto-oncogene probes were used in time-consuming analyses. Furthermore, sequences present in DMINs and HSRs could often not be identified, because of the limited number of suitable probes. In contrast, the approach of reverse chromosome painting gives an immediate clue regarding the chromosomal origin of amplified genomic sequences. Conventional analyses have often revealed only one amplified sequence in DMINs. However, since DMINs in tumors can result from co-amplification of sequences from different areas of the genome (Alitalo and Schwab 1986) , important information about amplified DNA might be missed. As demonstrated in this study, reverse chromosome painting allows us to visualize co-amplified chromosomal regions in a single experiment. Furthermore, this approach provides a tool for screening large numbers of cases with respect to chromosomal regions that are commonly amplified in a particular type of tumor, and also for studying the time course of amplification events during tumor development.
In principle, any cellular material from which DNA can be extracted can be used for this analysis. Thus, the reverse chromosome painting technique is particularly useful for cases in which the preparation of chromosome spreads fails, as for example in many solid tumors. The potential of the approach will be further increased if DNA from tissue sections obtained for routine diagnostic applications, such as paraffinembeded tissues, can be used as a probe. This would also allow the use of archived material for retrospective studies of tumor-associated chromosomal amplifications and other genetic imbalancies. With the advent of techniques for the general amplification of DNA by PCR using universal primers (e.g. degenerated oligonucleotide primed (DOP)-PCR, see Telenius et al. 1992) , it can be expected that even small tissue samples will be sufficient as source material.
Inspection of the signal intensities along chromosomes not only revealed stronger signals indicative of amplification, but also showed areas of weaker staining. With the GBM DNA, chromosomes 10 and X were consistently stained less intensely than the average painted chromosomes. Loss of chromosome l0 copies is found in 60% of all GBM cases (Bigner and Vogelstein 1990) . Thus, the weak labeling of chromosome 10 may indicate monosomy 10 in this tumor case demonstrating the detection of chromosome losses by reverse chromosome painting. Detailed analysis for accurately assessing such chromosomal gains and losses, including gonosomal hybridization patterns, is presented in du Manoir et al. (1993) .
